Mechanistically, tumor necrosis factor (TNF) from transferred cells induces dendritic cell (DC)-dependent expansion of host CD8<sup>+</sup> T cells, conferring protection against ACT-resistant tumor cells lacking the targeted antigen. The gene discussed is CD8A; the disease is neoplasm.